Diagnosis of interstitial lung disease
β Scribed by Andrew Bush
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 252 KB
- Volume
- 22
- Category
- Article
- ISSN
- 8755-6863
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The aim of this study is to characterize rituximabβinduced interstitial lung disease (RβILD). The information on all reported cases of RβILD was reviewed. This analysis focused on patient characteristics, underlying disease, rituximab dosing schedule, and RβILD characteristicβlike sympt
Intravenous pulse cyclophosphamide (IPC) was used to treat lupus interstitial lung disease in 2 patients. Vital capacity increased by 67-110% of baseline values with IPC treatment. Total lung capacity and diffusing capacity also improved. Dyspnea and other manifestations of lupus improved dramatical